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Abstract
Background Regulatory CD4+CD25+ T cells have been
proven to be essential for maintenance of peripheral
tolerance and autoimmune diseases. ACAID is a model of
immune privilege in the eye. Relatively little is known
about the role and phenotype of these regulatory
CD4+CD25+ T cells in ACAID.
Methods Injection of OVA into the anterior chamber of
BALB/C mice was performed to induce ACAID. The
frequencies of splenic CD4+CD25+ Tregs and the expres-
sion of CTLA-4 and LAG-3 on these cells were determined
by flow cytometry. Magnetic cell sorting was used to
isolate CD4+CD25+ and CD4+CD25−T cells. The function
of CD4+CD25+ T cells was detected by in vitro immuno-
suppression assays and in vivo adoptive transfer.
Results ACAID was successfully induced following an i.c.
injection of OVA. Frequencies of CD4+CD25+ and Tregs
were significantly increased in ACAID mice as compared
to those in controls. The CD4+CD25+ T cells stimulated
with OVA in ACAID mice showed a stronger suppressive
ability in vitro than those seen in non-ACAID mice.
CD4+CD25+ T cells from ACAID mice, but not from
non-ACAID mice, were able to suppress DTH responses in
an antigen-specific manner following adoptive transfer. The
frequencies of CTLA-4 or LAG-3 on Tregs in ACAID mice
were higher as compared with those in naive mice.
Conclusion Splenic CD4+CD25+Foxp3+T cells expressing
CTLA4 and LAG3 play an important role in the induction
of ACAID.
Keywords Regulatory Tcells . Immune regulation .
Foxp3 . ACAID
Introduction
Anterior chamber-associated immune deviation (ACAID), a
model of systemic immune tolerance, is characterized by an
antigen-specific suppression of delayed type hypersensitiv-
ity (DTH) and a selective deficiency of complement-fixing
antibodies (Abs) [16, 17]. DTH is inhibited by two types of
suppressor cells: one is a CD4+ T cell population that
inhibits the induction and the other is a CD8+T cell
population that suppresses DTH expression [20, 24].
CD4+T suppressor cells from ACAID mice are able to
transfer immune tolerance to naïve mice [21]. Further study
proved that CD4+T cells expressing CD25 and producing
IL-10 are required for the development of ACAID [19].
CD4+CD25+ regulatory T cells include two populations:
one naturally exists in thymus [10], the other is induced in
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the periphery [13]. A recent report suggests that develop-
ment of ACAID is independent of the naturally occurring
CD4+CD25+ regulatory T cell population [11]. This
suggests a possible role for antigen-specific CD4+CD25+
regulatory T cells during ACAID. In the study presented
here, we focused on a possible role of these regulatory T
cells from the spleen in the development of ACAID. This
was performed by quantifying CD4+CD25+ T cells during
the development of ACAID using a set of novel T cell
markers such as Foxp3, LAG-3 and CTLA-4.
Foxp3 is considered as an important marker for
regulatory T cells, and CD4+CD25+Foxp3+ T cells are
preferentially regarded as regulatory T cells (Tregs) [3, 4,
8]. LAG-3 selectively marks the induced regulatory
CD4+CD25+T cells [9], and CTLA-4 modulates the
suppressive activity of CD4+CD25+ T cells by providing
co-stimulatory signals [22].
Our results showed that Tregs were increased in ACAID
mice. Over 90% CD4+CD25+ T cells from ACAID mice,
positive controls, negative controls or naïve mice were
Foxp3 positive. Splenic Tregs expressed high levels of
CTLA-4 and LAG-3 in ACAID mice. Furthermore, we
showed that CD4+CD25+ T cells from the spleens of
ACAID mice could transfer tolerance when adoptively
transferred into naïve mice.
Materials and methods
Mice
Female 6- to 8-week old BALB/c mice were used in the
experiments. Mice were obtained from the Animal Center
of the Sun Yat-sen University (Guangzhou, China). Mice
were treated humanely and in accordance with the ARVO
statement for the use of animals in vision and ophthalmol-
ogy research.
Induction of ACAID and DTH assay
ACAID was induced as previously described [16]. In brief,
ACAID mice received an injection of 2-μl ovalbumin
(OVA, 20 mg/ml, Sigma, St. Louis, MO) dissolved in PBS
into the anterior chamber (AC) and were immunized on day
7 by subcutaneous (s.c.) injection 250 μg/200 μl of OVA or
bovine serum albumin (BSA, Amresco, USA) emulsified in
Complete Freudn’s adjuvant (CFA, Sigma, St. Louis, MO).
Mice only receiving a s.c. injection of OVA in CFA alone
served as positive controls. Mice receiving an intracameral
injection of 2 μl sterile PBS alone acted as negative
controls. Untreated mice were used as naïve controls.
DTH to specific alloantigen was measured using a
conventional ear swelling assay [16]. Ag (200 μg of
OVA/10 μl of PBS) and an equal volume of sterile PBS
were respectively injected into the right and left ear pinnae.
Ear pinnae of experimental and control animals were
measured with a Mitutoyo engineer’s micrometer (Mitutoyo,
Japan) immediately before challenge and 24 h later.
Phenotypes of Tregs determined by flow cytometry
Splenocytes were suspended in PBS and 0.1% BSA at a
final concentration of 1×106 cells/100 μl. These cells were
incubated with FITC-anti-CD3 mAb, FITC or APC-anti-
CD4 mAb, PE-cy7-anti-CD25 mAb and PE-anti-LAG-3
mAb for 30 min in the dark at 4°C. Cells were washed,
fixed and permeabilized and stained with APC or PE-anti-
Foxp3 mAb, PE-anti-CTLA-4 mAb or matched isotype
according to the manufacturer’s instructions and analyzed
by flow cytometry (FCM). All conjugated antibodies were
purchased from eBioscience and BD Pharmingen (San
Diego, CA).
CD4+CD25+ and CD4+CD25−T-cell selection
CD4+CD25+ T cells were isolated from mouse splenocytes
with a CD4+CD25+ Regulatory T Cells Isolation kit
(Miltenyi Biotec, Auburn, CA). Briefly, spleen cell suspen-
sions were incubated with a cocktail of biotin-conjugated
antibodies and anti-biotin microbeads for negatively sorting
CD4+T cells. The enriched CD4+T cells were incubated
with PE-labeled CD25+ and anti-PE microbeads for
positively sorting CD4+CD25+T cells. The purities of
isolated CD4+CD25+ or CD4+CD25−T cells identified by
flow cytometric analysis both were shown to be higher than
90%.
In vitro suppression assay of CD4+CD25+T cells
Splenocytes isolated from naïve BALB/c mice were used as
antigen presenting cells (APCs) and were treated with
50 μg/ml mitomycin-C (MMC, Sigma, St. Louis, MO) for
45 min at 37°C.These cells were washed three times with
RPMI-1640 (Gibco, USA) before incubation in prolifera-
tion assays. Purified CD4+CD25−T cells from positive
controls served as effector cells, and purified CD4+CD25+T
cells acted as regulator cells. Effector cells (2×104 cells/
well) cultured with or without OVA (200 μg/ml), MMC-
treated splenocytes (8×104 cells/well) and regulator cells
(2×104 cells/well) from each group were incubated in
RPMI-1640 medium, supplemented with 10% heat-inacti-
vated FCS, 50 μM 2-ME, 2 mM L-glutamine, 0.1 mM
nonessential amino acids, 1 mM sodium pyruvate and 1%
streptomycin/penicillin at 37°C for 72 h and pulsed with
1 μCi/well [3H]thymidine (Shanghai Institute of Applied
Physics, Chinese Academy of Sciences, China) during the
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last 16 h of incubation. T cell proliferation was determined
by the incorporation of [3H]thymidine. Proliferation data
were the mean value of triplicate wells and represented
three independent experiments.
In vivo suppression assay of CD4+CD25+T cells
The isolated CD4+CD25+T cells or CD4+CD25−T cells
were washed three times with PBS, resuspended in PBS
and subsequently injected intravenously into the tail vein of
naive BALB/c mice at a concentration of 5×105 or 5×106/
200 μl. Twenty-four hours later, recipients were s.c.
immunized with OVA in CFA or BSA in CFA. On day 7,
DTH responses were assayed according to the aforemen-
tioned method.
Statistics
The results were expressed as the mean±SEM. Data were
analyzed by ANOVA using SPSS11.0. A value of P<0.05
was considered significantly different.
Results
Frequency of splenic CD4+Tregs is increased in ACAID
mice
CD4+CD25+T cells have been shown to play a critical role
in immune tolerance and immune responses in various
diseases and experimental models of disease in rodents and
humans [5, 7, 12]. Our study aimed to examine whether
CD4+CD25+T cells were increased in ACAID, an eye-
derived immune tolerance model. The results showed that
ACAID was successfully induced by injection of OVA into
the anterior chamber of the mice as evidenced by a
markedly decreased delayed type hypersensitivity response
(Fig. 1). The frequency of splenic CD4+CD25+ T cells in
CD4+T cells from ACAID mice was significantly higher
than that from non-ACAID groups (P<0.01) (Fig. 2a).
As CD25 is not a definitive marker for regulatory T
cells, Foxp3 was used to further identify these cells [3, 4,
8]. The results showed that the frequency of splenic
CD4+CD25+Foxp3+ in CD4+T cells in ACAID mice were
slightly, but significantly increased as compared with that
observed in the control groups (P<0.05) (Fig. 2b), although
the frequencies of Foxp3 in CD4+CD25+T cells were
similar (all being more than 90%) (Fig. 2c). Foxp3 was
also found to be expressed by approximately 7% of
CD4+CD25−T cells. There was no significant difference
among these four groups concerning the frequency of
CD4+CD25−Foxp3+T cells in the spleen.
Splenic CD4+CD25+T cells from ACAID mice
have a stronger suppressive ability in vitro
To characterize the function of CD4+CD25+T cells and
CD4+CD25− T cells in vitro, these two populations were
purified from naïve mice, the positive control and the
ACAID group, and proved to be over 90% pure (Fig. 3a).
Purified CD4+CD25+T cells from three groups were
unresponsive to stimulation with OVA and APCs in vitro.
A slight proliferation of CD4+CD25−T cells was observed
upon exposure to APC alone, whereas these CD4+CD25−T
cells showed vigorous proliferation after stimulation with
OVA and APCs. We subsequently examined whether the
splenic CD4+CD25+T cells from ACAID mice had a
stronger regulatory activity than those from other groups.
The results revealed that CD4+CD25+T cells from each
group could inhibit the proliferation of effector cells
(CD4+CD25−T cells) in the presence or absence of OVA.
There was no significant difference concerning the sup-
pressive ability among these three groups without OVA.
However, CD4+CD25+T cells from ACAID mice had a
much stronger suppressive ability than those obtained from
naïve mice (P<0.01) or positive controls (P<0.01) in the
presence of OVA. There was no difference concerning the
suppressive ability between negative controls and positive
controls (Fig. 3b).
Adoptively transferred CD4+CD25+T cells from ACAID
mice significantly suppress DTH responses
The isolated CD4+CD25+T cells (5×105 cells per mouse) or
CD4+CD25−T (5×105 or 5×106 cells per mouse) from
Fig. 1 ACAID was successfully induced. ACAID mice received an
intracameral injection of OVA followed by s.c. immunization with
OVA in CFA after 7 days. Positive controls were immunized s.c. with
OVA in CFA. Negative controls received an intracameral injection of
sterile PBS. Naïve mice did not receive any stimulation. Mice were
challenged 14 days later by injection of antigen into the right ear
pinnae and an equal volume of sterile PBS into the left ear pinnae.
Delayed-type hypersensitivity responses were measured 24 h later.
The results shown are the means±SEM of three experiments
performed. In the ACAID group (n=4), DTH responses were
significantly suppressed compared with those in the positive control
group (n=4). *P<0.001
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naïve mice, positive control or ACAID mice were adop-
tively transferred into the tail vein of syngeneic mice. These
recipients were s.c. immunized with OVA in CFA or BSA
in CFA 24 h later. On day 7 DTH responses were assayed.
The results, as shown in Fig. 4, revealed that the
CD4+CD25+T cells from ACAID mice, but not from non-
ACAID mice, could adoptively transfer DTH inhibition.
When a large number of CD4+CD25− T cells (5×106 cells
per mouse) from ACAID mice were transferred, DTH
responses could also be suppressed, but not as strongly as
when CD4+CD25+T cells had been transferred. Moreover,
transferred CD4+CD25+T cells from the ACAID mice
induced by OVA did not show any effect on the ear
swelling of those mice receiving a s.c. injection of BSA in
CFA and challenged with BSA, showing the antigen
specificity of the transferred cells (P<0.01).
Expression of CTLA-4 and LAG-3 on CD4+Tregs
in ACAID mice is increased
As CTLA-4 and LAG-3 have been shown to be involved in
the function of regulatory CD4+CD25+T cell, we went on to
study the expression of CTLA-4 and LAG-3 on Tregs in
ACAID [9, 22]. The results showed that the frequency of
Fig. 2 The frequencies of CD4+CD25+ and CD4+CD25+Foxp3+T cells
among CD4+T cells. All the spleens from each group were harvested
on day 7 after the last treatment. Splenocytes were prepared as
described in the methods section and stained with anti-CD3, anti-CD4,
anti-CD25 mAb and anti-Foxp3 mAb. Data in the quadrant indicate
the percentage of positive cells, and derive from gating on CD3+CD4+
cells. a: The frequency of CD4+CD25+ among CD4+T cells; b: the
frequency of CD4+CD25+Foxp3+ among CD4+T cells; c: the per-
centages of CD4+CD25+Foxp3+ on CD4+CD25+ T cells or
CD4+CD25−Foxp3+ on CD4+CD25−T cells. The frequencies of
CD4+CD25+ and CD4+CD25+Foxp3+T cells among CD4+T cells in
the ACAID group (n=4) are significantly increased compared with
those in the positive control (n=4). There is no significant difference in
the percentages of CD4+CD25+Foxp3+ on CD4+CD25+ T cells or
CD4+CD25−Foxp3+ on CD4+CD25−T cells between the ACAID group
and the positive control group. One representative dot blot of four
independent experiments is shown. The results shown in the histogram
are the means±SEM of four independent experiments. *P<0.05
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Foxp3+CTLA-4+ in CD4+CD25+T cells (Fig. 5a) was
significantly increased in ACAID mice and positive
controls as compared with that in naïve and negative
controls (P<0.01). There was no significant difference
concerning the frequency of Foxp3+CTLA-4+CD4+CD25+T
cells between ACAID mice and positive controls, although
a tendency for a light increase was observed in the former.
The frequency of Foxp3+LAG-3+ in CD4+CD25+T cells
(Fig. 5b) in ACAID mice was significantly higher than that
in naïve, negative controls and positive controls (P<0.01).
Discussion
The results presented in this paper provide strong evidence
for an important role for CD4+CD25+Foxp3+T cells (Tregs)
expressing a high level of CTLA-4 and LAG-3 in the
development of ACAID. Our earlier work has shown that
CD4+PD-1+T cells played a potent regulatory role in
ACAID. PD-1, a negative regulatory molecule in the
CD28/B7 family, may be a marker for CD4+ regulatory
cells [14]. In the present paper, our experiments showed
that the frequency of Tregs was significantly increased in
ACAID mice compared to the non-ACAID groups. A vast
majority of CD4+CD25+T cells (>90%) in all groups were
Foxp3 positive. CD4+CD25+T cells from ACAID mice
displayed a stronger inhibitory ability to CD4+CD25−T
cells in vitro as compared with that observed in naïve mice
and positive controls. CD4+CD25+T cells from ACAID
mice, but not from non-ACAID mice, were able to
adoptively transfer tolerance to naïve mice. Our further
phenotypic analysis of Tregs in ACAID mice showed that
these cells expressed higher levels of both CTLA-4 and
LAG-3. Taken together, these results suggest that both
CD4+PD-1+T cells and CD4+CD25+Foxp3+T cells may be
the subpopulations of the CD4+ suppressor cell in ACAID.
It has been shown that ACAID is a phenomenon
mediated or maintained by generating an active regulatory
T cell population to suppress DTH [15]. Regulatory CD4+T
cells are one of the suppressive populations responsible for
the development of ACAID [2]. These CD4+ T cells are
highly enriched with a subpopulation expressing the IL-
2Rα chain (CD25) [13]. In our study, the frequencies of
CD4+CD25+ and CD4+CD25+Foxp3+T cells were signifi-
cantly higher in ACAID mice as compared with those in
non-ACAID groups. In an attempt to exclude the influence
of intracameral injection on the frequency of CD4+CD25+T
cells as well as CD4+CD25+Foxp3+T cells, an experiment
Fig. 2 (continued)
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with PBS injection into the anterior chamber was per-
formed. This experiment showed that this manipulation did
not influence the frequency of these cells. All these results
suggest that an upregulation of Tregs occurs during
ACAID.
Tregs are clearly shown to be increased following an
intracameral injection of OVA in our study. It is important
to test if these cells have a suppressive property. In vitro
experiments revealed that this population without stimula-
tion had a suppressive ability on CD4+CD25− effector T
cells, no matter if they were obtained from ACAID mice,
positive mice or naïve mice. Upon stimulation with OVA,
these CD4+CD25+T cells from ACAID mice showed a
stronger suppressive activity than those from the other two
groups. These results suggest that OVA-specific
CD4+CD25+Tregs are induced during ACAID. Our in vivo
experiment showed that DTH responses were impaired by
adoptively transferring splenic CD4+CD25+T cells from
ACAID mice, but not from non-ACAID mice. These results
indicate that splenic CD4+CD25+T cells in ACAID mice
are not identical to natural Tregs in naïve mice, and seem to
have a stronger immunosuppressive capacity. As ACAID is
Fig. 2 (continued)
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an immune tolerance induced by foreign antigens, it is
presumed that these CD4+CD25+T cells with an antigen-
specific inhibitory function (Tregs) play a crucial role in the
development of this immune deviation. Future studies using
Foxp3−/− mice may further clarify their role. Additionally,
time response studies should be performed in the future to
determine the half-life of the suppressive activity of
CD4+CD25+T cells generated during ACAID. It is interest-
ing to note that a ten-fold higher number of CD4+CD25−T
cells from ACAID mice, when adoptively transferred to
naïve mice, could also suppress DTH responses, although
the suppression was weaker than when transferring
CD4+CD25+T cells. This result suggests that a subset of
regulatory T cells with a weak suppressive property or in a
very small frequency also exists in the CD4+CD25−T cells
subpopulation. It has been found that a small proportion of
CD4+CD25−T cells express Foxp3 [4]. In our experiment
we also found that about 7% of these T cells express Foxp3.
It is possible that the observed suppressive activity could be
ascribed to these Foxp3-expressing CD4+CD25−T cells
This is consistent with a recent report that both
CD4+CD25+ and CD4+CD25− regulatory cells mediate
dominant transplantation tolerance [6]. We cannot rule out
the possibility that contamination with CD4+CD25+T cells
may also be involved in the inhibition of the DTH response
observed when using high numbers of CD4+CD25−T cells.
Activation of CD25− cells into CD25+ cells following
injection can also explain the observed findings. Further
studies are needed to clarify this issue.
As CD4+CD25+Foxp3+T cells in ACAID mice showed
an increased frequency and suppressive ability, we further
explored the phenotype of this regulatory population.
Fig. 3 Suppressive effect of CD4+CD25+T cells on CD4+CD25− effector
T cells in vitro. a: The purity of isolated of CD4+CD25+ (left) and
CD4+CD25− T (right) cells by MACS; b: the suppressive effect of
CD4+CD25+T cells on the proliferation of CD4+CD25− T cells.
Splenocytes from naïve mice were treated with mitomycin-C as APC.
CD4+CD25− effector T cells (2×104 cells/per well) from positive control
were cultured with or without OVA (200 μg/ml), APC (8×104 cells/per
well) and equal numbers of CD4+CD25+T cells (regulator cells, 2×104
cells/per well), respectively, from naïve mice, positive controls and ACAID
mice. The cells were cultured for 72 h and pulsed with [3H]thymidine for
the last 16 h of culture. Splenic CD4+CD25+T cells stimulated with OVA
have a stronger suppressive ability when obtained from ACAID mice than
from the other two groups.Data are the means±SEM of triplicate samples
and are representative of three independent experiments. *P<0.01
Fig. 4 DTH responses to adoptive transferred cells. Splenic CD4+CD25+
and CD4+CD25− T cells from naïve mice, positive controls and ACAID
mice were sorted by MACS. Isolated CD4+CD25+T cells (5×105 cells/per
mouse), CD4+CD25−T cells (5×106 cells/per mouse) or PBS were
injected intravenously into the tail vein of syngeneic mice. At 24 h, the
recipients received a s.c. injection of OVA or BSA in CFA. On day 7, the
mice were challenged by injection of OVA (10 μl) into the right ear pinnae
and an equal volume of sterile PBS into the left. DTH responses were
measured 24 h later. Splenic CD4+CD25+ T cells or large numbers of
CD4+CD25− T cells from ACAID mice transferred suppression of DTH
responses. Each group contained four animals. The experiments were
repeated two times. All results are expressed as mean±SEM. * P<0.01
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CTLA-4 and LAG-3, two important molecules for Tregs,
were studied for their expression in Tregs from ACAID
mice as well as other groups. Our study revealed an
increased expression of LAG-3 in Tregs in ACAID mice as
compared with that seen in the various control groups used,
suggesting that LAG-3 may be involved in the specific
regulation in this immune tolerance. The results also
showed an increased expression of CTLA-4 in Tregs in
ACAID mice as well as in the positive group, although a
little higher expression was observed in the former. As
CTLA-4 is a marker of activated Tregs, it is likely that
these CTLA-4-expressing Tregs in the positive control are
Fig. 5 The frequencies of
CTLA-4+Foxp3+ or LAG-
3+Foxp3+cells among
CD4+CD25+T cells. All the
spleens from each group were
harvested on day 7 after the last
treatment. Splenocytes were
prepared as described in the
methods section and CD4+T
cells were required by negative
sorting. CD4+T cells were
stained with anti-CD4, anti-
CD25, anti-Foxp3 and anti-
CTLA-4 or anti-LAG-3 mAb.
Data in the quadrants indicated
the percentage of positive cells
that derived from gating on
CD4+CD25+T cells. a: The fre-
quencies of CTLA-4+Foxp3+
among CD4+CD25+T cells; b:
the frequencies of LAG-
3+Foxp3+cells among
CD4+CD25+T cells. The fre-
quency of CTLA-4+Foxp3+ or
LAG-3+Foxp3+cells among
CD4+CD25+T cells in ACAID
group (n=4) was markedly in-
creased compared with the neg-
ative control group (n=4). One
representative dot blot of four
independent experiments is
shown. The results shown in the
histogram are the means±SEM
of four independent experi-
ments. *P<0.01
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those primed by complete Freund’s adjuvant used in this
study. As the number of LAG-3+ T cells are very low and
CD4+CD25+Foxp3+CTLA-4+ T cells are not isolated by
MACS, further studies with CTLA-4 or LAG-3 knockout
mice or using anti-CTLA-4 or anti-LAG-3 antibodies to
block the corresponding pathway will greatly help us to
clarify the exact role of CTLA-4 or LAG-3 in the induction
of ACAID. A number of regulatory molecules, such as
GITR, PD-1 and BTLA, have been recently documented [1,
2, 18, 23]. It is also necessary to investigate their role in
Tregs in the development of ACAID.
In conclusion, our results suggest that CD4+CD25+Foxp3+T
cells expressing a high level of CTLA-4 and LAG-3 represent
an important subset of CD4+Tregs in ACAID. However,
further studies on the phenotype and function of regulatory
cells will provide more profound insight into the development
of ACAID.
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